Virtu Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Virtu Financial’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,719	Closed	-$111K	–	1263
2023 Q2	$111K	Buy	+35,719	New	+$76.1K	0.01%	1011
2022 Q4	–	Sell	-21,605	Closed	-$44K	–	1561
2022 Q3	$44K	Buy	+21,605	New	+$60.5K	﹤0.01%	1230
2022 Q2	–	Sell	-26,099	Closed	-$109K	–	1548
2022 Q1	$109K	Buy	+26,099	New	+$116K	0.01%	955
2021 Q4	–	Sell	-34,927	Closed	-$187K	–	1672
2021 Q3	$187K	Buy	+34,927	New	+$176K	0.02%	937
2021 Q2	–	Sell	-17,147	Closed	-$115K	–	1475
2021 Q1	$115K	Buy	+17,147	New	+$95K	0.01%	1280
2019 Q3	–	Sell	-22,036	Closed	-$158K	–	1406
2019 Q2	$158K	Buy	+22,036	New	+$225K	0.01%	1065
2019 Q1	–	Sell	-16,694	Closed	-$226K	–	1386
2018 Q4	$226K	Buy	+16,694	New	+$301K	0.01%	886

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's AMRX Position: Q3 2023 in Review

Virtu Financial sold out of Amneal Pharmaceuticals (AMRX) in Q3 2023, closing a stake of 35,719 shares — an estimated $111K sold.

Virtu Financial first reported a position in AMRX in Q4 2018 and held it in 7 quarters. The position peaked at $226K in Q4 2018. 144 funds tracked by Wall St. Rank hold AMRX as of Q3 2023.

Virtu Financial reported no remaining Amneal Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 35,719 Amneal Pharmaceuticals shares in Q3 2023, an estimated $111K.
Virtu Financial first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 7 quarters.
Virtu Financial's Amneal Pharmaceuticals position peaked at $226K in Q4 2018.
144 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.